Cormorant Asset Management, LP ENLIVEN THERAPEUTICS INC Transaction History

Cormorant Asset Management, LP

  • $992 Million
  • Q2 2025
Number of Shares
200,000
Previous 250,000 20.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-50,000 Reduced 20.0%
200,000 $0
Q4 2024

Feb 14, 2025
BUY
N/A
250,000 New
250,000 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-719,421 Reduced 37.16%
1,216,712 $0
Q1 2023

May 15, 2023
BUY
N/A
1,936,133 New
1,936,133 $42.4 Million
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email